Advances in Oncology reviews the year’s most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Editorial Board - p. iii 6. Contributors - p. v 7. Preface - p. xvii 8. SECTION I: RADIATION ONCOLOGY - p. xviii 9. Radiation Therapy to Prolong Systemic Therapy Benefit Across Solid Tumors - p. 1 10. SECTION II: SURGICAL ONCOLOGY - p. 12 11. Management of Desmoid Tumors - p. 13 12. Management of Advanced Thyroid Cancer: An Update - p. 23 13. Current State and Future Therapeutic Opportunities for Gallbladder Cancer - p. 31 14. SECTION III: GYNECOLOGIC ONCOLOGY - p. 43 15. Role of Circulating Tumor DNA as a Tool in the Management of GYN Malignancies - p. 45 16. Gestational Trophoblastic Neoplasia: A Review of the Evidence and Emerging Therapies - p. 63 17. SECTION IV: PEDIATRIC ONCOLOGY - p. 73 18. Application and Considerations for an Evolving Therapeutic Landscape - p. 75 19. Beyond CD19: New Targets for CAR T-cell Therapy in Acute Myeloid Leukemia - p. 87 20. SECTION V: NEURO-ONCOLOGY - p. 96 21. Brachytherapy for Gliomas: A Rekindle - p. 97 22. Neurologic Complications in Immuno-oncology: Chimeric Antigen Receptor T-Cell Therapies and T-Cell Engagers - p. 109 23. SECTION VI: HEMATOLOGICAL ONCOLOGY - p. 127 24. A Fixed-Duration Bispecific Antibody Strategy for Treatment of Multiple Myeloma - p. 129 25. Measurable Residual Disease-Driven Approach to Frontline Treatment for Chronic Lymphocytic Leukemia in Younger and/or Fit Patients - p. 145 26. SECTION VII: URO-ONCOLOGY - p. 163 27. Treatment Approaches and Future Directions for Neuroendocrine Prostate Cancer and Other Aggressive Variant Prostate Cancers - p. 165 28. Non-clear Cell Renal Cell Carcinoma: Current Knowledge and Future Directions - p. 173 29. SECTION VIII: GASTROINTESTINAL ONCOLOGY - p. 184 30. Current Interventional Radiology Strategies for Liver Metastases - p. 185 31. De-escalation Treatment Strategies for Gastrointestinal Malignancies - p. 209 32. Contemporary Approaches to the Care of Older Adults with Gastrointestinal Cancers - p. 223
Advances in Oncology reviews the year’s most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Editorial Board - p. iii 6. Contributors - p. v 7. Preface - p. xvii 8. SECTION I: RADIATION ONCOLOGY - p. xviii 9. Radiation Therapy to Prolong Systemic Therapy Benefit Across Solid Tumors - p. 1 10. SECTION II: SURGICAL ONCOLOGY - p. 12 11. Management of Desmoid Tumors - p. 13 12. Management of Advanced Thyroid Cancer: An Update - p. 23 13. Current State and Future Therapeutic Opportunities for Gallbladder Cancer - p. 31 14. SECTION III: GYNECOLOGIC ONCOLOGY - p. 43 15. Role of Circulating Tumor DNA as a Tool in the Management of GYN Malignancies - p. 45 16. Gestational Trophoblastic Neoplasia: A Review of the Evidence and Emerging Therapies - p. 63 17. SECTION IV: PEDIATRIC ONCOLOGY - p. 73 18. Application and Considerations for an Evolving Therapeutic Landscape - p. 75 19. Beyond CD19: New Targets for CAR T-cell Therapy in Acute Myeloid Leukemia - p. 87 20. SECTION V: NEURO-ONCOLOGY - p. 96 21. Brachytherapy for Gliomas: A Rekindle - p. 97 22. Neurologic Complications in Immuno-oncology: Chimeric Antigen Receptor T-Cell Therapies and T-Cell Engagers - p. 109 23. SECTION VI: HEMATOLOGICAL ONCOLOGY - p. 127 24. A Fixed-Duration Bispecific Antibody Strategy for Treatment of Multiple Myeloma - p. 129 25. Measurable Residual Disease-Driven Approach to Frontline Treatment for Chronic Lymphocytic Leukemia in Younger and/or Fit Patients - p. 145 26. SECTION VII: URO-ONCOLOGY - p. 163 27. Treatment Approaches and Future Directions for Neuroendocrine Prostate Cancer and Other Aggressive Variant Prostate Cancers - p. 165 28. Non-clear Cell Renal Cell Carcinoma: Current Knowledge and Future Directions - p. 173 29. SECTION VIII: GASTROINTESTINAL ONCOLOGY - p. 184 30. Current Interventional Radiology Strategies for Liver Metastases - p. 185 31. De-escalation Treatment Strategies for Gastrointestinal Malignancies - p. 209 32. Contemporary Approaches to the Care of Older Adults with Gastrointestinal Cancers - p. 223
